European School of Oncology

By improving the skills of all health professionals dealing with cancer patients, ESO helps shorten the time needed to transfer knowledge from research centres to daily practice, combining advanced technology with humanism in care.

ESO’s mission is reflected in its motto “Learning to Care”, which emphasises the importance of the ...
read more ↘

 

Lymphoma Course
18:40

ESO Lymphoma Course

Chemo-free Therapy for Follicular Lymphoma - Rituximab as Single Agent, Rituximab + Lenalidomide & Other Combinations

FEATURING Emanuele Zucca
  • 162 views
  • August 19, 2019
39:10

ESO Lymphoma Course

Hodgkin Lymphoma - Kairos vs. Chronos Principle & New Active Agents (Antibody-Drug Conjugates and Checkpoint Antibodies)

FEATURING Peter Johnson
  • 74 views
  • August 19, 2019
14:43

ESO Lymphoma Course

The Mutational Landscape of CLL: Diagnosis, Survival, and Watch and Wait

FEATURING Davide Rossi
  • 331 views
  • August 19, 2019
  • 2
19:04

ESO Lymphoma Course

The Mutational Landscape of CLL: 1st line, Fixed Duration Treatment, TP53 Status, 2nd Line Setting and MRD

FEATURING Davide Rossi
  • 178 views
  • August 19, 2019
  • 1
22:43

ESO Lymphoma Course

R-CHOP Therapy for 61 y/o Male with Stage IIIB bulky DLBCL & Avoiding Radiotherapy if PET-Negative

FEATURING Alden Moccia
  • 13 views
  • August 30, 2019
23:01

ESO Lymphoma Course

Treatment of 58 y/o Male with Stage IV B Marginal Zone lLymphoma : Transformation of Disease into DLBCL

FEATURING Alden Moccia
  • 46 views
  • August 30, 2019
31:37

ESO Lymphoma Course

Efficacy and Safety of Anti-CD19 CAR T-cell Therapy in B-cell Lymphoma, Update on ZUMA - 1 Trial & Strategies for Improving Efficacy of CAR T Therapy

FEATURING Sattva Neelapu
  • 122 views
  • September 3, 2019
  • 1
26:51

ESO Lymphoma Course

Management of Mantle Cell Lymphoma: Prognostic Factors, Younger vs. Older Treatment Algorithms & Efficacy of R-BAC After Progression on BTKi Therapy

FEATURING Simon Rule
  • 74 views
  • September 3, 2019
31:53

ESO Lymphoma Course

Update on Primary and Secondary CNS Lymphoma: Diagnosis, Treatment Options, Review of Top Trials and Salvage Therapy

FEATURING Tracy Batchelor
  • 63 views
  • September 3, 2019
18:27

ESO Lymphoma Course

Update on Waldenstrom's Macroglobulinemia: Somatic Mutation in MYD88 and CXCR4, Review of Available Treatment Options & Ongoing Trials

FEATURING Bernhard Gerber
  • 141 views
  • September 3, 2019
22:17

ESO Lymphoma Course

First Line DLBCL: How Many Cycles of RCHOP? Improving Outcomes of CHOP: R-CHOP vs. R-ACVBP vs. DA-EPOCH-R, R-CODOX-M vs. R-IVAC

FEATURING Andrew Davies
  • 243 views
  • September 3, 2019
  • 1
18:20

ESO Lymphoma Course

Should We Add Other Agents Like Obinutuzumab, Lenalidomide, Bortezomib or Ibrutinib to R-CHOP? How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis?

FEATURING Andrew Davies
  • 52 views
  • September 3, 2019
09:10

ESO Lymphoma Course

Evolution of Cancer Therapies: Molecular Selection of Patients, Histology Agnostic Therapies & Costs and Success Rates in Oncology Drug Development

FEATURING Anastasios Stathis
  • 15 views
  • September 4, 2019
09:22

ESO Lymphoma Course

Main Phases of Clinical Drug Development, New Trials Designs (Umbrella Trial vs. Basket Trial) & Seamless Oncology Drug Development

FEATURING Anastasios Stathis
  • 16 views
  • September 4, 2019
07:54

ESO Lymphoma Course

Current and Future Drug Development in DLBCL: Review of Methodology, Failure History & New Trial Design

FEATURING Anastasios Stathis
  • 29 views
  • September 4, 2019
21:39

ESO Lymphoma Course

Case of 58 y/o Male with IgM Multiple Myeloma and Amyloidosis: Disease Progression and Discussion on Best Treatment Options

FEATURING Bernhard Gerber
  • 66 views
  • September 5, 2019
11:39

ESO Lymphoma Course

Treatment of 57 y/o Male with B-Lymphoblastic Lymphoma

FEATURING Bernhard Gerber
  • 26 views
  • September 5, 2019
32:00

ESO Lymphoma Course

The AML Paradigm: From 3+7 for Everybody to Genetic-Driven Personalized Treatment

FEATURING Martin Fey
  • 231 views
  • September 5, 2019
  • 2
33:55

ESO Lymphoma Course

Pathogenesis of Mature B-Cell Lymphomas: Germinal Center‐derived Lymphomas, Somatic Mutations, MALT1 Inhibitor, Metabolic Adaptation & SIRT3 Metabolic Target

FEATURING Ari Melnick
  • 89 views
  • September 12, 2019
22:37

ESO Lymphoma Course

Common "Epigenetic" Somatic Mutations in Lymphoma: CREBBP, EP300, HDAC3, TET2, KMT2D, EZH2

FEATURING Ari Melnick
  • 48 views
  • September 12, 2019
16:32

ESO Lymphoma Course

Biology of T-cell Lymphoma: PTCL Molecular Characterisation & Entities, Follicular Helper, Mutations and Epigenetic Modifiers

FEATURING Laurence de Leval
  • 37 views
  • September 12, 2019
12:07

ESO Lymphoma Course

Biology of Anaplastic Large Cell Lymphomas (ALK+ and ALK-) & Breast Implant‐associated ALCL

FEATURING Laurence de Leval
  • 29 views
  • September 12, 2019
17:15

ESO Lymphoma Course

Biology of Extranodal NK/T-cell Lymphoma: Mutations and Pathways, EATL vs MEITL, ATLL Genomic Profiling & Genetic Profiling of PTCLS-NOS

FEATURING Laurence de Leval
  • 30 views
  • September 12, 2019
  • 1
28:05

ESO Lymphoma Course

Biology of Hodgkin Lymphoma: IgV Gene Rearrangements, Factors Contributing to Lost B Cell Identity of HRS Cells & Genetic Lesions in HRS Cells

FEATURING Ralf Küppers
  • 22 views
  • September 12, 2019
22:48

ESO Lymphoma Course

Biology of Hodgkin Lymphoma: Relationship Between Hodgkin and Reed-Sternberg Cells & Gene Expression Profiling Analysis of CD30+ B vs. HRS Cells

FEATURING Ralf Küppers
  • 22 views
  • September 12, 2019